About
Sergey Jakimov is a founding partner and managing partner at LongeVC, a venture capital firm investing in early-stage biotech and longevity companies. He also co-founded Longenesis and the Longevity Science Foundation, and publicly appears as a speaker and lecturer on venture capital, intellectual property, and longevity innovation. Official bios describe him as a serial entrepreneur who has raised more than $50 million across his own ventures and entrepreneur-in-residence work.
Areas of interest
longevitybiotechnologygerosciencehealthspantherapeuticsdiagnosticsprecision medicineoncologyimmuno-oncologyepigenetic reprogrammingneurodegenerative diseasecellular senescenceAI drug discoveryclinical trialsintellectual propertymedical devicesdigital healthpsychedelic therapeuticsdeep technologyhealthcare infrastructure